267 related articles for article (PubMed ID: 31863623)
1. Relationship between polycomb-group protein BMI-1 and phosphatases regulating AKT phosphorylation level in endometrial cancer.
Zaczek A; Jóźwiak P; Ciesielski P; Forma E; Wójcik-Krowiranda K; Cwonda Ł; Bieńkiewicz A; Bryś M; Krześlak A
J Cell Mol Med; 2020 Jan; 24(2):1300-1310. PubMed ID: 31863623
[TBL] [Abstract][Full Text] [Related]
2. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T
Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro.
Li F; Liang A; Lv Y; Liu G; Jiang A; Liu P
Med Sci Monit; 2017 Oct; 23():5139-5149. PubMed ID: 29080395
[TBL] [Abstract][Full Text] [Related]
4. Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit.
Bertacchini J; Mediani L; Beretti F; Guida M; Ghalali A; Brugnoli F; Bertagnolo V; Petricoin E; Poti F; Arioli J; Anselmi L; Bari A; McCubrey J; Martelli AM; Cocco L; Capitani S; Marmiroli S
J Cell Physiol; 2019 Jul; 234(7):11188-11199. PubMed ID: 30565691
[TBL] [Abstract][Full Text] [Related]
5. Depletion of Pleckstrin homology domain leucine-rich repeat protein phosphatases 1 and 2 by Bcr-Abl promotes chronic myelogenous leukemia cell proliferation through continuous phosphorylation of Akt isoforms.
Hirano I; Nakamura S; Yokota D; Ono T; Shigeno K; Fujisawa S; Shinjo K; Ohnishi K
J Biol Chem; 2009 Aug; 284(33):22155-22165. PubMed ID: 19261608
[TBL] [Abstract][Full Text] [Related]
6. miR‑494‑3p promotes the progression of endometrial cancer by regulating the PTEN/PI3K/AKT pathway.
Zhu L; Wang X; Wang T; Zhu W; Zhou X
Mol Med Rep; 2019 Jan; 19(1):581-588. PubMed ID: 30431102
[TBL] [Abstract][Full Text] [Related]
7. Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancer.
Hu J; Liu YL; Piao SL; Yang DD; Yang YM; Cai L
Lung Cancer; 2012 Sep; 77(3):593-9. PubMed ID: 22717106
[TBL] [Abstract][Full Text] [Related]
8. PHLPPing through history: a decade in the life of PHLPP phosphatases.
Grzechnik AT; Newton AC
Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677
[TBL] [Abstract][Full Text] [Related]
9. Turning off AKT: PHLPP as a drug target.
Newton AC; Trotman LC
Annu Rev Pharmacol Toxicol; 2014; 54():537-58. PubMed ID: 24392697
[TBL] [Abstract][Full Text] [Related]
10. CBX7 suppresses cell proliferation, migration, and invasion through the inhibition of PTEN/Akt signaling in pancreatic cancer.
Ni S; Wang H; Zhu X; Wan C; Xu J; Lu C; Xiao L; He J; Jiang C; Wang W; He Z
Oncotarget; 2017 Jan; 8(5):8010-8021. PubMed ID: 28030829
[TBL] [Abstract][Full Text] [Related]
11. PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma.
Molina JR; Agarwal NK; Morales FC; Hayashi Y; Aldape KD; Cote G; Georgescu MM
Oncogene; 2012 Mar; 31(10):1264-74. PubMed ID: 21804599
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
[TBL] [Abstract][Full Text] [Related]
13. miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer.
Cai J; Fang L; Huang Y; Li R; Yuan J; Yang Y; Zhu X; Chen B; Wu J; Li M
Cancer Res; 2013 Sep; 73(17):5402-15. PubMed ID: 23856247
[TBL] [Abstract][Full Text] [Related]
14. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
[TBL] [Abstract][Full Text] [Related]
15. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and PH domain and leucine-rich repeat phosphatase cross-talk (PHLPP) in cancer cells and in transforming growth factor β-activated stem cells.
Ghalali A; Ye ZW; Högberg J; Stenius U
J Biol Chem; 2014 Apr; 289(17):11601-11616. PubMed ID: 24599953
[TBL] [Abstract][Full Text] [Related]
16. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells.
Song LB; Li J; Liao WT; Feng Y; Yu CP; Hu LJ; Kong QL; Xu LH; Zhang X; Liu WL; Li MZ; Zhang L; Kang TB; Fu LW; Huang WL; Xia YF; Tsao SW; Li M; Band V; Band H; Shi QH; Zeng YX; Zeng MS
J Clin Invest; 2009 Dec; 119(12):3626-36. PubMed ID: 19884659
[TBL] [Abstract][Full Text] [Related]
17. The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation.
Nitsche C; Edderkaoui M; Moore RM; Eibl G; Kasahara N; Treger J; Grippo PJ; Mayerle J; Lerch MM; Gukovskaya AS
Gastroenterology; 2012 Feb; 142(2):377-87.e1-5. PubMed ID: 22044669
[TBL] [Abstract][Full Text] [Related]
18. PTEN and PHLPP crosstalk in cancer cells and in TGFβ-activated stem cells.
Ghalali A; Ye ZW; Högberg J; Stenius U
Biomed Pharmacother; 2020 Jul; 127():110112. PubMed ID: 32294598
[TBL] [Abstract][Full Text] [Related]
19. [Significance of phosphoinositide 3 kinase/AKT pathway alterations in endometrial carcinoma].
Yang X; Dong Y; Zhang XM; Liang Y; Zhang Y; Meng YT; Wang Y; Wang W; Nong L; Li T; Liao QP
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):799-804. PubMed ID: 22336203
[TBL] [Abstract][Full Text] [Related]
20. JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer.
Qiu H; Li J; Clark LH; Jackson AL; Zhang L; Guo H; Kilgore JE; Gehrig PA; Zhou C; Bae-Jump VL
Oncotarget; 2016 Oct; 7(41):66809-66821. PubMed ID: 27572308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]